HRMY
Harmony Biosciences Holdings Inc Earnings
$40.51
Earnings Summary
Revenue | $239.46Mn |
Net Profits | $50.87Mn |
Net Profit Margins | 21.24% |
Harmony Biosciences Holdings Inc’s revenue jumped 28.71% since last year same period to $239.46Mn in the Q3 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 19.44% jump in its revenue since last 3-months.
Harmony Biosciences Holdings Inc’s net profit jumped 10.35% since last year same period to $50.87Mn in the Q3 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 27.88% jump in its net profits since last 3-months.
Harmony Biosciences Holdings Inc’s net profit margin fell -14.26% since last year same period to 21.24% in the Q3 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 7.07% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.81 |
EPS Estimate Current Year | 0.81 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 0.81 - a 13.18% jump from last quarter’s estimates.
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current year stand at 0.81.
Key Ratios
Earning Per Share (EPS) | 0.92 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) jumped 360% since last year same period to 0.92 in the Q2 2025. This indicates that the Harmony Biosciences Holdings Inc has generated 360% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-05 | 0.72 | 0.92 | 27.78% |
2025-05-06 | 0.91 | 0.78 | -14.79% |
